Primary Immunodeficiency disease (PID) is a wide genre of inborn defects that affect the patients immune system. More than 430 distinct phenotypes have been reported and more are being identified. Traditional treatments to PID include clearance or prevention of infections, avoidance of exposure to pathogen and live vaccines, immunoglobulin replacement therapy, and haematopoietic stem cell transplantation (HSCT). Mostly HSCT would be the only feasible radical solution, while others only offer temporary suppression of the condition. On the other hand, with the advancements in technology, gene therapy starts to show promising effects in multiple diseases including PID. In this review, we mainly discussed the effect and resent progresses of gene therapy on two common kinds of PID, SCID and WAS.